MedTrace Logo

Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease

NCT03245606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2020-07-14

No results posted yet for this study

Summary

The main objective is to compare the accuracy of transient elastography taking into account liver steatosis determined by MRI, to liver biopsy for the diagnosis of liver fibrosis ≥F2 in patient with NAFLD.

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

PROCEDURE

Liver biopsy

Measurement of liver fibrosis

DEVICE

Abdominal MRI

Measurement of liver fibrosis

DEVICE

Transient elastography

Measurement of liver fibrosis

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-07
Primary Completion
2020-07-07
Completion
2020-07-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03245606 on ClinicalTrials.gov